BridgeMD
Prevention study for Primary Angle Glaucoma Closure Suspect
Official title Danish Angle Closure Prevention Trial
ClinicalTrials.gov ID: NCT06077253
What this study is testing
- What it's testing
- To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP\<21mmHg, no peripheral anterior...
- Best-corrected visual acuity (BCVA) \>0.8 on both eyes
- Caucasian
You likely can't join if
- Pseudophakia
- Previous iridotomy
- Clinically significant cataract with indication for surgery,
- Gaucoma
- Uveitis
- Unstable retinal conditions
See the full eligibility criteria
- Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP\<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy
- Best-corrected visual acuity (BCVA) \>0.8 on both eyes
- Caucasian
- Pseudophakia
- Previous iridotomy
- Clinically significant cataract with indication for surgery,
- Gaucoma
- Uveitis
- Unstable retinal conditions
- Ocular malignancies
- Systemic or ocular corticosteroid treatment
The study team makes the final eligibility decision.
Where it's taking place
- Aalborg, Denmark
- Aarhus, Denmark
- Glostrup Municipality, Denmark
- Odense, Denmark
- Vejle, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aalborg, Denmark; Aarhus, Denmark; Glostrup Municipality, Denmark; Odense, Denmark; Vejle, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.